NEW YORK, NY, Dec 18, 2013 — The executives at Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary, Medical Marijuana Sciences, Inc., had to take note of recent results released in a marijuana study done by a group of researchers in Spain. The study used a type of encapsulation to inhibit brain cancer cell growth in mice. These researchers seem to be speaking Nuvilex’s language with the biotech’s recent acquisitions of exclusive worldwide rights to a cellulose-based live-cell encapsulation technology known as Cell-in-a-Box(TM) for the development of treatments for diabetes and for any and all types of cancer. In the study, […]
Medbox Sponsors Drugstore News’ Collaborative Care Continuing Education Webinar
Course provides Continuing Education Credit for Pharmacists WEST HOLLYWOOD, Calif., Dec. 17, 2013 — Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced that they will be the sponsor of Drugstore News’ Collaborative Care Continuing Education Webinar. The course will be held tonight, December 17, 2013 at 8:30 pm EST. The program is titled “Medical Marijuana in the United States: New Issues for an Old Plant.” The course is designed for pharmacists, and provides a full Continuing Education (CE) credit. The course instructor is Laura M. […]
Organization Challenges Drug Czar to Explain the Self-Contradiction He Included In An Invitation to TODAY’s First-Ever White House Drug Policy Reform Conference
WASHINGTON, D.C. — The Marijuana Policy Project is challenging U.S. Drug Czar Gil Kerlikowske to explain the self-contradicting statement he included in an invitation to the first-ever White House Drug Policy Reform Conference, which will be held Monday from 9 a.m.–2 p.m. It can be viewed online at http://www.whitehouse.gov/live The email invitation distributed Friday by the Office of National Drug Control Policy included a graphic with the following quote from Kerlikowske: “Drug policy reform should be rooted in NEUROSCIENCE—NOT POLITICAL SCIENCE.” “Every objective study on marijuana has concluded that it poses far less harm to the brain than alcohol,” said […]
Medical Marijuana Inc.’s Hemp Cannabidiol (CBD) Product Portfolio Featured on Fox News and CNBC
In Response to Public’s Interest in Industrial Hemp-Based Cannabidiol (CBD) Oil Products, HempMedsPX(TM) Expands Event Calendar SAN DIEGO, Nov. 12, 2013 — Medical Marijuana, Inc. (OTC Pink:MJNA) andHempMedsPX™ — a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. — gained an exclusive feature by Fox News and was included in an industry overview by CNBC as the company continues its mission of increasing public awareness of open availability of industrial hemp-based cannabidiol (CBD) oil products that HempMedsPX™ represents. Charles Vest, HempMedsPX VP of Communications explains benefits of Hemp CBD Oil New Cibdex and Cibaderm […]

